Piramal Pharma Solutions (PPS) is pleased to announce that it was recognized as a winner at the CMO Leadership Award 2018 in all six categories. The event was held on March 21st, 2018 in New York during the Drug, Chemical and Associated Technologies
Vivek Sharma, Chief Executive Officer at Piramal Pharma Solutions said “We are delighted to be recognized again at the CMO Leadership Awards, this is the sixth consecutive year that we have won. To be one of the few service providers to be recognized in all six categories is humbling, and I would like to congratulate the entire PPS team for their efforts. I also want to thank our customers for their continued trust in us, as we seek to serve the needs of the end patients. ”
Vivek Sharma added, “Piramal Pharma Solutions continues to make significant strides as we build around the pillars of Customer Centricity, Innovation, and Quality, with an emphasis on scientific excellence. We are focused on investing in our customers’ future needs, and be the ‘integrated partner of choice’ for pharma and biotech organizations, world-wide.”
7th edition of the CMO Leadership Awards, conducted by Life Science Leader magazine, provides industry veterans with accurate and reliable customer feedback to assist them in choosing a reputable partner for their development and manufacturing needs. The recipients are evaluated by the customers they have actually worked with, and include six critical categories of capabilities, compatibility, expertise, quality, reliability and service. An award in any of these categories adds to the distinction and reputation of CMOs throughout the global drug discovery, development, manufacturing and marketing industries. This year, more than 110 contract manufactures were assessed by 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey.
Piramal Pharma Solutions is the Contract Development and Manufacturing arm of Piramal Group with operations across North America, Europe and Asia. Piramal is a global leader in integrated solutions and offers a unique platform of services across the drug lifecycle – from drug discovery and development through commercial manufacturing of drug substance and drug product. With accreditations from regulatory bodies from North America, Europe and Japan, our development centers and manufacturing sites across the globe have a pool of over 700 scientists committed to research & development programs. Our capability as an integrated service provider & experience with various technologies enables us to serve innovator and generic companies worldwide.